Breathing in a special gas to watch a new drug fight lung disease
NCT ID NCT06351345
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests whether a special type of MRI, using inhaled xenon gas, can show how well the drug sotatercept is working in people with pulmonary arterial hypertension (PAH). PAH is a serious condition where blood vessels in the lungs narrow, making the heart work harder. The study will involve about 14 adults and aims to see if the MRI can detect improvements in lung blood flow without needing invasive tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.